Evidence map›Paper›PMID 24303086›Full record

ArticleOxidative medicine and cellular longevity2013

Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats.

Min Liu, Bin Zhou, Zhong-Yuan Xia, Bo Zhao, Shao-Qing Lei, Qing-Jun Yang, Rui Xue, Yan Leng, Jin-Jin Xu, Zhengyuan Xia

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. DJ-1 Serves as a Central Regulator of Diabetes Complications.Current issues in molecular biology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Selective Inhibition of PKCJournal of diabetes research · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Min LiuDepartment of Anesthesiology, Renmin Hospital of Wuhan University, 99 Zi Yang Road, Wuhan, Hubei 430060, China.
Bin Zhou
Zhong-Yuan Xia
Bo Zhao
Shao-Qing Lei
Qing-Jun Yang
Rui Xue
Yan Leng
Jin-Jin Xu
Zhengyuan Xia
Wuhan University · CNGuangdong Medical College · CNFirst Affiliated Hospital of University of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia postconditioning (IpostC) is an effective way to alleviate ischemia and reperfusion injury; however, the protective effects seem to be impaired in candidates with diabetes mellitus. To gain deep insight into this phenomenon, we explored the role of DJ-1, a novel oncogene, that may exhibit powerful antioxidant capacity in postconditioning cardioprotection in a rat model of myocardial ischemia reperfusion injury. Compared with normal group, cardiac DJ-1 was downregulated in diabetes. Larger postischemic infarct size as well as exaggeration of oxidative stress was observed, while IpostC reversed the above changes in normal but not in diabetic rats. DJ-1 was increased after ischemia and postconditioning contributed to a further elevation; however, no alteration of DJ-1 was documented in all subgroups of diabetic rats. Alteration of the cardioprotective PI3K/Akt signaling proteins may be responsible for the ineffectiveness of postconditioning in diabetes. There is a positive correlation relationship between p-Akt and DJ-1 but a negative correlation between infarct size and DJ-1, which may partially explain the interaction of DJ-1 and IpostC cardioprotection. Our result indicates a beneficial role of DJ-1 in myocardial ischemia reperfusion. Downregulation of cardiac DJ-1 may be responsible for the compromised diabetic heart responsiveness to IpostC cardioprotection.

Indexed as

Ischemic PostconditioningAnimalsBlood GlucoseBody WeightCardiotonic AgentsDiabetes Mellitus, ExperimentalHeart VentriclesHyperglycemiaLinear ModelsMaleMicrotubule-Associated ProteinsMyocardial InfarctionPhosphorylationProtein Deglycase DJ-1Proto-Oncogene Proteins c-aktRatsBlood GlucoseCardiotonic AgentsMicrotubule-Associated ProteinsPARK7 protein, ratProtein Deglycase DJ-1Proto-Oncogene Proteins c-aktReactive Oxygen Species

Identifiers

PMID24303086
PMCPMC3835206
OpenAlexW2053171249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.